Announcements Trials

Browse Landscape

Phase

Status

Recruiting 13 Active not recruiting 3 Completed 2 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

pembrolizumab 20 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Cyclophosphamide 11 fludarabine 10 Radiotherapy 9 Biopsy 9 atezolizumab 7 Nivolumab 7 Radiation 6 Gemcitabine 5 fludarabine phosphate 4 aldesleukin 4 Prednisone 4 Etoposide 4 Cytarabine 4 Cisplatin 4 Carboplatin 4 Blood Specimen Collection 4 ALT-803 4 lenvatinib 3 avelumab 3 X-Rays 3 Vincristine 3 Surveys and Questionnaires 3 Rituximab 3 Phantoms, Imaging 3 Paclitaxel 3 Oxaliplatin 3 Lenalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × patritumab deruxtecan × 1 year × Clear all

NCT05620914 2025-06-15

PARAMETer

Duke University

Phase 2 Withdrawn

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡